Anyone more learned than myself who can provide the current status of our Fragile X trial? Last i can seem to find is the Chairman's address release on 29/06/2017 in which Dr T mentioned they are designing the next clinical trial. No updates on this. I feel the Rett valuation for a deal would be a fait accompli. The Fragile X is the unknown and would be the complex negotiating points.
Add to My Watchlist
What is My Watchlist?
